NCI epidemiologist whose HPV natural history studies underpin HPV-based cervical screening and risk-based management worldwide.
Mark Schiffman led the Guanacaste and Portland Kaiser cohorts that defined the natural history of HPV infection and cervical precancer, work that established HPV testing as a screening test, single-dose vaccine efficacy signals, and the risk-based ASCCP management guidelines. He leads NCI efforts on automated visual evaluation with AI and self-sampling to bring screening to low-resource settings.
| Title | Journal | Year |
|---|---|---|
| Human papillomavirus and cervical cancer | Lancet | 2007 |
| Carcinogenic human papillomavirus infection | Nature Reviews Disease Primers | 2016 |
| Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening | BMJ | 2018 |
Shares HPV & HBV vaccination, Cervical cancer and the tags hpv, epidemiology.
Shares HPV & HBV vaccination, Cervical cancer and the tags hpv, screening.
Shares Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening, HPV & HBV vaccination, Cervical cancer.
Shares Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening, Cervical cancer.
Shares Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening, Cervical cancer.
Shares the tags screening, epidemiology.
Shares the tags screening, epidemiology.
Shares the tags screening, epidemiology.